



I Departamento de Anatomia e Cirurgia, Universidade de São Paulo - Ri-
beirão Preto/SP, Brazil.
II Department of Physiology and Biomedical Engineering, Mayo Clinic - 
Rochester/Minnesota, USA.
Email: nmmatsuda@uol.com.br
Tel: 55 16 3633.0836
Received for publication on August 27, 2009
Accepted for publication on September 18, 2009 
THE CHRONIC GASTROINTESTINAL 
MANIFESTATIONS OF CHAGAS DISEASE
Nilce Mitiko Matsuda,I Steven M. Miller,II Paulo R. Barbosa EvoraI 
 
doi: 10.1590/S1807-59322009001200013
Matsuda NM, Miller SM, Évora PRB. The chronic gastrointestinal manifestations of chagas disease. Clinics. 2009;64(12):1219-24
Chagas disease is an infectious disease caused by the protozoan Trypanosoma cruzi. The disease mainly affects the nervous system, 
digestive system and heart. The objective of this review is to revise the literature and summarize the main chronic gastrointestinal 
manifestations of Chagas disease. The chronic gastrointestinal manifestations of Chagas disease are mainly a result of enteric 
nervous system impairment caused by T. cruzi infection. The anatomical locations most commonly described to be affected by 
Chagas disease are salivary glands, esophagus, lower esophageal sphincter, stomach, small intestine, colon, gallbladder and bili-
ary tree. Chagas disease has also been studied in association with Helicobacter pylori infection, interstitial cells of Cajal and the 
incidence of gastrointestinal cancer.
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INTRODUCTION
Chagas disease, named after the Brazilian physician, 
bacteriologist and epidemiologist Carlos Chagas who first 
described it a hundred years ago, is a tropical parasitic 
disease caused by the flagellate protozoan Trypanosoma 
cruzi (T. cruzi).1-3
The parasite T. cruzi is commonly transmitted to humans 
and other mammals by a vector insect, the blood-sucking 
bugs of the subfamily Triatominae.1,2 This disease can also 
be transmitted by blood transfusion, organ transplantation, 
from a mother to her fetus and by ingestion of food 
contaminated with the parasites.4,5
Several years or even decades after the initial infection, 
approximately 30% of infected people develop medical 
problems from Chagas disease over the course of their 
lives.4 Chagas disease mainly affects the nervous system, 
gastrointestinal tract and heart. Most people suffer 
cardiac damage, including cardiomyopathy, heart rhythm 
abnormalities and often an apical aneurysm.3,4
Approximately one third of patients can develop dilation 
of the gastrointestinal tract (megacolon, megaesophagus, 
megas tomach ,  megaduodenum,  mega j e junum, 
megagallbladder, megacholedochus) and gastrointestinal 
motor disorders, such as achalasia of the cardia, disturbances 
of gastric emptying, altered intestinal transit and colon and 
gallbladder motor disorders.3,4,6-18 Chagas disease is known 
to cause both central nervous system and enteric nervous 
system injury.3,4 The chronic gastrointestinal manifestations 
of Chagas disease are mainly a result of enteric nervous 
system injury caused by T. cruzi infection.19-25
The objective of this review is to revise the literature and 
summarize the main chronic gastrointestinal manifestations 
described in association with Chagas disease in the year of 
the hundredth anniversary of the first description of Chagas 
disease.
DISCUSSION
The chronic gastrointestinal manifestations of Chagas 
disease are described in the salivary glands, esophagus, 
lower esophageal sphincter, stomach, small intestine, colon, 
gallbladder and biliary tree.3,4,6-18,26 These alterations seem 
to develop from both excitatory and inhibitory enteric motor 
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innervation impairments.19-24 The chronic gastrointestinal 
manifestations of Chagas disease are described in association 
with Helicobacter pylori (H. pylori) infection, damage to the 
interstitial cells of Cajal and the incidence of gastrointestinal 
cancer.27-34 
From a total of 4,690 autopsies, 1,708 chagasic chronic 
post-mortem examinations were performed, and megacolon 
was the most frequent gastrointestinal manifestation, 
followed by megaesophagus. Megacolon associated with 
the megaesophagus was the third most common finding.35
The salivary gland manifestations of Chagas disease
Sialorrhea has been described in association with 
megaesophagus in both patients with Chagas disease and 
those with idiopathic megaesophagus.36 Salivary gland 
hypertrophy and sialorrhea have been described not only 
in association with chagasic megaesophagus and idiopathic 
achalasia, but also in association with other eating disorders, 
including bulimia and anorexia nervosa.36-38 Both salivary 
gland hypertrophy and sialorrhea seem to be related to the 
symptoms of vomiting and regurgitation described in these 
eating disorders and idiopathic and chagasic achalasia.36-38
The esophagus and the lower esophageal sphincter 
manifestations of Chagas disease
Chagasic achalasia and its consequence of chagasic 
megaesophagus are common findings in Chagas disease, 
and dysphagia may be the first symptom of digestive 
disturbances that may lead to malnutrition and severe weight 
loss.8,9,35,39,40
The nitric oxide (NO) donor drugs were used at the 
first half of the last century to increase emptying of the 
megaesophagus and to improve the symptoms of dysphagia 
in idiopathic achalasia.41-44 In chagasic achalasia, there are 
reports of the use of such drugs for the same purpose in 
the middle of the last century. However, the presentation 
of NO-donor drugs and their side effects has limited their 
use. Only later, with the presentation of such drugs in the 
form of tablets to be administered orally or sublingually, 
it was demonstrated that NO-donor drugs decrease lower 
esophageal sphincter pressure, improve the symptoms of 
dysphagia and increase megaesophagus clearance in both 
idiopathic achalasia and chagasic achalasia.45-53 Researchers 
finally demonstrated similarities between the inhibitory 
non-adrenergic non-cholinergic mediator and the substance 
released from NO-donor drugs in the late 1980s.54,55
Although chagasic achalasia presents with symptoms 
and radiological findings similar to those of idiopathic 
achalasia, some important differences are described.9, 56-
58
 It has been demonstrated that, in patients with Chagas 
disease, pressure in the lower esophageal sphincter is lower 
than in normal patients, whereas the pressure is higher in 
patients with idiopathic achalasia.7,40 Higher pressure in the 
lower esophageal sphincter in idiopathic achalasia relative 
to that in controls has also been demonstrated by others 
researchers.59,60 Reduced pressure in the lower esophageal 
sphincter in chagasic achalasia further demonstrates that 
both innervations, excitatory and inhibitory, are damaged 
in contrast to idiopathic achalasia, where the excitatory 
innervation is preserved, thereby causing the pressure to be 
higher than in the normal subjects.39,40,59-61 Similarities are 
also observed in the treatments, including pharmacological, 
endoscopic and surgical procedures.62,63 In both cases, 
treatment is palliative, with an objective of decreasing 
lower esophageal sphincter pressure, improving esophageal 
emptying and relief of the symptoms of dysphagia.62,63
The stomach manifestations of Chagas disease
The megastomach is neither a common nor an important 
finding of gastrointestinal manifestation in Chagas disease, 
although alterations in both motility and secretion have been 
described. Delayed gastric emptying of solid meals has been 
demonstrated. The explanation provided for this observation 
is that the excitatory motor enteric neurons are damaged in 
Chagas disease.13,64 Fast gastric emptying of liquid meals was 
also demonstrated, and the explanation was related not only 
to impairment of the excitatory enteric neurons, but also to 
impairment of inhibitory enteric neurons.12, 15
Given that inhibitory innervation is responsible for 
gastric accommodation after a meal, the stomach is not 
able to relax after a liquid meal once inhibitory enteric 
innervation is damaged, which results in rapid gastric 
emptying.12,15
Moreover, electrogastrography performed in patients 
with Chagas disease showed a higher incidence of gastric 
dysrhythmias in the chagasic patients than in the normal 
subjects.26 Another alteration demonstrated in patients with 
Chagas disease is that both basal and stimulated acid gastric 
secretion were lower than in normal subjects.65,66
The small intestine manifestations of Chagas disease
Abnormalities of interdigestive motility of the small 
intestine in Chagas disease have been described.67 
Manometric studies of gastrointestinal motility showed 
abnormally slow propagation of the interdigestive migrating 
motor complex, which was also excessively prolonged.66,67 
Although not common, dilation of the small intestine, 
such as megaduodenum and megajejunum, has also been 
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described.14,18 However, fast transit in the dilated small 
intestine in Chagas disease has been associated with 
bacteria overgrowth with chronic diarrhea, malabsorption, 
steatorrhea and hypocalcemia that improved with oral 
antibiotic therapy.14,18 Patients with Chagas disease have a 
combination of very fast gastric emptying and abnormally 
delayed transit of liquids through the more distal segments 
of the small bowel.15 Also, disorders of absorption in the 
small intestine were demonstrated in Chagas disease as an 
abnormal increase in the absorption of carbohydrates.2,10
The colonic manifestations of Chagas disease
Another common manifestation of Chagas disease in 
the gastrointestinal tract is chagasic megacolon. Chronic 
constipation is the main symptom related to megacolon.4, 
6,8,35
 Although chagasic megacolon presents with symptoms 
and radiological findings similar to congenital megacolon, 
differences are also related to damage in both excitatory 
and inhibitory innervations.19,20,22,24,25 Manometric studies in 
chagasic patients have demonstrated the basal motility index 
and wave frequency of the sigmoid colon and rectum to be 
lower than in normal subjects. In addition, the studies show a 
lack of relaxation of the internal sphincter of the anus in the 
chagasic patients.6,11 Others have demonstrated an absence 
of the rectoanal inhibitory reflex in the chagasic megacolon, 
similar to that in Hirschsprung’s disease.68,69 Alteration 
of the rectoanal inhibitory reflex in most of the chagasic 
patients with megacolon was demonstrated by several 
researchers and can be justified by the destruction of enteric 
motor innervations.6,11,19,20,22,24,25,68,70 The choice of surgical 
treatment appears to have the same indication as a solution for 
constipation in both chagasic and idiopathic megacolon.71,72
The incidence of diverticula in the sigmoid colon of the 
non-chagasic group was higher than in both the chagasic 
group with and without megacolon.73 Among the patients 
with megacolon and diverticular disease, the diverticula 
were always located in the non-dilated portions of the large 
bowel, suggesting that unfavorable conditions for the genesis 
or maintenance of diverticula exist in the dilated colon of the 
chagasic patients.73
The gallbladder and the biliary tree manifestations of 
Chagas disease
Gallbladder neuron counts in cholelithiasis in patients 
with Chagas disease have demonstrated a reduction in the 
number of neurons in the gallbladder wall.21 Given that the 
enteric excitatory motor neurons are damaged in Chagas 
disease, the prevalence of cholelithiasis, megagallbladder 
and megacholedochus is higher.74,75 Despite controversial 
results, a scintigraphic study of gallbladder emptying 
in Chagas disease showed that the gallbladder of the 
chagasic patients was much more sensitive to an exogenous 
cholecystokinetic agent and contracted in a more intense 
manner, with contraction starting earlier and lasting longer 
than among the controls, suggesting more severe impairment 
of the inhibitory enteric innervations.17
H. pylori infection and Chagas disease
In addition to studies in developing countries, which 
have a higher incidence of infection by H. pylori, Chagas 
disease has a higher incidence of peptic changes and a 
high frequency of peptic disease associated with H. pylori 
infection.29,76 Another study showed that the prevalence of 
infection by H. pylori was higher in the chagasic patients 
than in non-chagasic subjects from both urban and rural 
areas.31 Furthermore, H. pylori was considered a possible 
factor related to the etiopathogenesis of chronic superficial 
and atrophic gastritis, since it was frequently observed in 
patients with the gastrointestinal manifestations of Chagas 
disease.34,77
The interstitial cells of Cajal and Chagas disease
Injury to the interstitial cells of Cajal as well as the 
enteric nervous system have been considered important in 
gastrointestinal motility control.78,79 
Despite the controversy regarding the pathogenic role 
of defects in the interstitial cells of Cajal in idiopathic 
constipation and other gastrointestinal motor disorders, 
changes in the distribution of the interstitial cells of Cajal 
have been reported in various conditions, such as achalasia, 
chronic intestinal pseudo-obstruction, infantile hypertrophic 
pyloric stenosis, Hirschsprung’s disease, inflammatory 
bowel disease and slow transit constipation.77-87 In addition, 
altered distribution of the interstitial cells of Cajal has been 
demonstrated in chagasic megaesophagus and in chagasic 
megacolon.27,28,30
The incidence of gastrointestinal cancer and Chagas 
disease
The association of cancer of the esophagus and 
megaesophagus has been demonstrated to be both higher 
and lower in chagasic patients than in normal subjects.33,88 
Since a higher prevalence of gastric lesions and infection by 
H. pylori has been demonstrated, an increased incidence of 
cancer in the chagasic megaesophagus can be expected.34, 89-91
A review of 4,690 necropsies and 24,209 surgical 
specimens showed that the prevalence of malignant tumors 
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of the large bowel was not higher in chagasic megacolon.32 
Other authors also showed no association between chagasic 
megacolon and an increased incidence of cancer.33 Thus, 
Chagas disease affects several gastrointestinal regions, but 
there is no apparent relationship with the increased incidence 
of cancer and chagasic megacolon, and the main causes of 
death in elderly chagasic patients are commonly related 
instead to heart disease.32,33,92
SUMMARY
Chagas disease is an infectious disease that is described 
to mainly affect the central nervous system, heart and 
gastrointestinal tract. The objective of this review is to 
revise and summarize the main chronic gastrointestinal 
manifestations described in association with Chagas disease.
Chagas disease is related to several chronic gastro-
intestinal disorders resulting from damage to both 
excitatory and inhibitory enteric motor innervations, 
leading to megaesophagus, megacolon, megasmall intestine, 
megagallbladder, megacholedochus, achalasia of the cardia, 
changes in gastric receptive relaxation, fast gastric emptying 
of liquid meals, delayed gastric emptying of solid meals, 
altered small intestine transit and impairment of colon and 
gallbladder motility.
Chagas disease is also related to hypertrophy of the 
salivary glands, increased saliva production, decreased acid 
gastric production and altered small intestinal absorption. 
In addition, more peptic gastric lesions, a higher incidence 
of H. pylori infection, a similar incidence of cancer in 
the colon, a higher incidence of cancer in esophagus and 
altered distribution of the interstitial cells of Cajal in the 
megaesophagus and megacolon have also been demonstrated 
in association with Chagas disease.
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